Cumulative meta-analysis of epidermal growth factor receptor-tyrosine kinase inhibitors as first-line therapy in metastatic non-small-cell lung cancer
2021 ◽
Vol 30
(3)
◽
pp. 253-263
Keyword(s):
2015 ◽
Vol 33
(15_suppl)
◽
pp. e19124-e19124
Keyword(s):